Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1993 Dec 11;307(6918):1541–1546. doi: 10.1136/bmj.307.6918.1541

Summary of 1993 World Health Organisation-International Society of Hypertension guidelines for the management of mild hypertension. Subcommittee of WHO/ISH Mild Hypertension Liaison committee.

PMCID: PMC1679536  PMID: 8274926

Abstract

As part of the ongoing process of issuing guidelines for managing hypertension the World Health Organisation and International Society of Hypertension present a summary of the latest guidelines for the management of mild hypertension. In both young and elderly people this condition is a risk factor for cardiovascular disease and should be treated. Information is presented on methods of diagnostic evaluation and assessment of risk. Methods of treatment, including changes in lifestyle, are covered.

Full text

PDF
1541

Images in this article

1543p1543-a
on p.1543
1545p1545-a
on p.1545

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amery A., Birkenhäger W., Brixko P., Bulpitt C., Clement D., Deruyttere M., De Schaepdryver A., Dollery C., Fagard R., Forette F. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet. 1985 Jun 15;1(8442):1349–1354. doi: 10.1016/s0140-6736(85)91783-0. [DOI] [PubMed] [Google Scholar]
  2. Collins R., Peto R., MacMahon S., Hebert P., Fiebach N. H., Eberlein K. A., Godwin J., Qizilbash N., Taylor J. O., Hennekens C. H. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990 Apr 7;335(8693):827–838. doi: 10.1016/0140-6736(90)90944-z. [DOI] [PubMed] [Google Scholar]
  3. Cruickshank J. M., Thorp J. M., Zacharias F. J. Benefits and potential harm of lowering high blood pressure. Lancet. 1987 Mar 14;1(8533):581–584. doi: 10.1016/s0140-6736(87)90231-5. [DOI] [PubMed] [Google Scholar]
  4. Dahlöf B., Lindholm L. H., Hansson L., Scherstén B., Ekbom T., Wester P. O. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension) Lancet. 1991 Nov 23;338(8778):1281–1285. doi: 10.1016/0140-6736(91)92589-t. [DOI] [PubMed] [Google Scholar]
  5. Evans J. G., Rose G. Hypertension. Br Med Bull. 1971 Jan;27(1):37–42. doi: 10.1093/oxfordjournals.bmb.a070812. [DOI] [PubMed] [Google Scholar]
  6. Further analyses of mortality in oral contraceptive users. Royal College of General Practitioners' Oral Contraception Study. Lancet. 1981 Mar 7;1(8219):541–546. [PubMed] [Google Scholar]
  7. Julius S., Jamerson K., Gudbrandsson T., Schork N. White coat hypertension: a follow-up. Clin Exp Hypertens A. 1992;14(1-2):45–53. doi: 10.3109/10641969209036170. [DOI] [PubMed] [Google Scholar]
  8. Kannel W. B., Dawber T. R., McGee D. L. Perspectives on systolic hypertension. The Framingham study. Circulation. 1980 Jun;61(6):1179–1182. doi: 10.1161/01.cir.61.6.1179. [DOI] [PubMed] [Google Scholar]
  9. Koren M. J., Devereux R. B., Casale P. N., Savage D. D., Laragh J. H. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 1991 Mar 1;114(5):345–352. doi: 10.7326/0003-4819-114-5-345. [DOI] [PubMed] [Google Scholar]
  10. Levy D., Garrison R. J., Savage D. D., Kannel W. B., Castelli W. P. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990 May 31;322(22):1561–1566. doi: 10.1056/NEJM199005313222203. [DOI] [PubMed] [Google Scholar]
  11. MacMahon S., Peto R., Cutler J., Collins R., Sorlie P., Neaton J., Abbott R., Godwin J., Dyer A., Stamler J. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990 Mar 31;335(8692):765–774. doi: 10.1016/0140-6736(90)90878-9. [DOI] [PubMed] [Google Scholar]
  12. Mancia G., Parati G., Pomidossi G., Grassi G., Casadei R., Zanchetti A. Alerting reaction and rise in blood pressure during measurement by physician and nurse. Hypertension. 1987 Feb;9(2):209–215. doi: 10.1161/01.hyp.9.2.209. [DOI] [PubMed] [Google Scholar]
  13. Parving H. H., Hommel E. Prognosis in diabetic nephropathy. BMJ. 1989 Jul 22;299(6693):230–233. doi: 10.1136/bmj.299.6693.230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. The Hypertension Optimal Treatment Study (the HOT Study). Blood Press. 1993 Mar;2(1):62–68. doi: 10.3109/08037059309077529. [DOI] [PubMed] [Google Scholar]
  15. Wren B. G., Routledge D. A. Blood pressure changes: oestrogens in climacteric women. Med J Aust. 1981 Nov 14;2(10):528–531. doi: 10.5694/j.1326-5377.1981.tb112974.x. [DOI] [PubMed] [Google Scholar]
  16. Zanchetti A. Goals of antihypertensive treatment: prevention of cardiovascular events and prevention of organ damage. Blood Press. 1992 Dec;1(4):205–211. doi: 10.3109/08037059209077664. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES